Exchange: NSE·Updated 04:00 PM GMT+5:30

GLENMARK.NSE News

News
all
press releases
US tariffs on metals and pharma: Which Indian stocks are safe and which aren't: Sudip Bandyopadhyay
Indian equity markets face policy risks from US tariffs and West Asia conflict. These issues impact metals and pharmaceutical sectors. Expert Sudip Bandyopadhyay provides stock-specific insights. Vedanta and NALCO are well-positioned in aluminium. Tata Steel faces uncertainty due to European operations. Sun Pharma and Glenmark are at risk in the pharmaceutical sector due to branded drug exposure.
cityfalcon.com
US tariffs on metals and pharma: Which Indian stocks are safe and which aren't: Sudip Bandyopadhyay
Indian equity markets face policy risks from US tariffs and West Asia conflict. These issues impact metals and pharmaceutical sectors. Expert Sudip Bandyopadhyay provides stock-specific insights. Vedanta and NALCO are well-positioned in aluminium. Tata Steel faces uncertainty due to European operations. Sun Pharma and Glenmark are at risk in the pharmaceutical sector due to branded drug exposure.
cityfalcon.com
More News
… suggested three stocks including Glenmark Pharmaceuticals Ltd, Cummins India and Indian … , supporting further upside potential. Glenmark Pharmaceuticals | Buy | Target Price: Rs 2 … Loss: Rs 1,988 Glenmark Pharma is displaying a constructive bullish setup …
cityfalcon.com
… (Glenmark), a research-led, global pharmaceutical company, today announced the launch of … been approved by the Central Drugs Standard Control Organization (CDSCO) … Business Head, India Formulations, Glenmark Pharmaceuticals Ltd., said, "Affordability …
cityfalcon.com
As the patents for semaglutide near expiry in several countries this month, India has introduced a cost-effective alternative.
Stocktwits
… Reddy’s Laboratories, Sun Pharma , Glenmark Pharmaceuticals , Alkem Laboratories, Zydus Lifesciences … , and Natco Pharma . Eris Lifesciences, which has a … first Indian pharma company to receive approval from the Drugs Controller General …
cityfalcon.com
… markets." Another homegrown pharma major, Glenmark Pharmaceuticals Ltd also launched its …
cityfalcon.com
The new U.S. duty has already triggered a slide in major Asian pharma names, raising concerns about how Indian peers will react in the coming weeks.
Stocktwits
The analyst highlights breakout opportunities in these stocks, provided that critical support levels are maintained.
Stocktwits
The company has submitted a Clinical Trial Application to start the study in Russia and is preparing sites in Brazil and Mexico
Stocktwits

Advertisement|Remove ads.